An International Society of Gynecologic Endoscopy symposium will serve as a platform for medical director Thomas L. Lyons, MD, an Atlanta-based Center for Women’s Care and Reproductive Surgery to deliver a presentation on robotic surgery in March.
Thomas L. Lyons, MD, Center for Women's Care & Reproductive Surgery
Complementing his credits following the development of Laparoscopic Supracervical Hysterectomy in 1989, Dr. Tom Lyons said that the robotic surgery is not just a major marketing tool for hospitals. Its application is comprehensive.
The minimally invasive surgeon has already developed the LSH and the laparoscopic Burch technique for urinary stress incontinence.
Summarized below are the opinions of Dr. Lyons on robotic surgery:
- Robotic surgery is not equivalent to training in endoscopy and every physician in that specific area cannot be considered as a minimally invasive surgeon.
- Robotic surgery is not capable of preventing infection and it does not improve the outcomes regarding patient’s health.
- Insurance companies are no more responsible for robotic equipment. There is an overall increase in surgical costs with global expansion of robotic procedures. This applies to other standard procedures where robotic equipment is not even used.
- Robotic surgery entails an increased level of expertise on the surgeon, and not on the robot. The expertise is based on the input of work and efficiency of the practitioner, and not the device.
- Although robot manufacturers spend a lot of money on validation and determination of robotic techniques, the above given facts are true and are supported by 10 years for trials and studies.
The International Society of Gynecologic Endoscopy symposium will take place in association with the World Robotic Gynecology Congress IV scheduled from March 27-31, 2012 in Orlando.
Source: International Society of Gynecologic Endoscopy